We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-14.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.12B
Cap. Flow %
-0.82%
Top 10 Hldgs %
21.65%
Holding
3,641
New
264
Increased
1,460
Reduced
1,409
Closed
415

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
UNH icon
UnitedHealth
UNH
+$463M
3
ORCL icon
Oracle
ORCL
+$392M
4
ELV icon
Elevance Health
ELV
+$387M
5
PEP icon
PepsiCo
PEP
+$343M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$321M
2
BIDU icon
Baidu
BIDU
+$269M
3
NVDA icon
NVIDIA
NVDA
+$262M
4
ABBV icon
AbbVie
ABBV
+$260M
5
GM icon
General Motors
GM
+$248M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Healthcare 13.99%
3 Financials 12.35%
4 Consumer Discretionary 10.52%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWH icon
2901
ESS Tech
GWH
$18.9M
$713K ﹤0.01%
+16,915
New +$1.19M
EGAN icon
2902
eGain
EGAN
$201M
$712K ﹤0.01%
73,015
+8,993
+14% +$89.7K
NOAH
2903
Noah Holdings
NOAH
$603M
$712K ﹤0.01%
35,200
-19,295
-35% -$360K
BCML icon
2904
BayCom
BCML
$333M
$711K ﹤0.01%
+34,390
New +$758K
IMVT icon
2905
Immunovant
IMVT
$8.25B
$708K ﹤0.01%
181,517
-41,568
-19% -$180K
ITIC
2906
Investors Title Co
ITIC
$547M
$702K ﹤0.01%
4,473
+68
+2% +$11.7K
MCRB icon
2907
Seres Therapeutics
MCRB
$48.4M
$702K ﹤0.01%
10,243
-2,452
-19% -$211K
PDYN icon
2908
Palladyne AI
PDYN
$296M
$699K ﹤0.01%
+43,854
New +$1.09M
PFHD
2909
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$696K ﹤0.01%
+34,718
New +$763K
KLRS
2910
Kalaris Therapeutics
KLRS
$96.8M
$694K ﹤0.01%
7,742
+4,228
+120% +$443K
ENFN
2911
DELISTED
Enfusion, Inc.
ENFN
$692K ﹤0.01%
67,760
+17,642
+35% +$195K
SPNE
2912
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$691K ﹤0.01%
122,257
+13,881
+13% +$121K
EVCM icon
2913
EverCommerce
EVCM
$1.93B
$689K ﹤0.01%
76,230
+22,937
+43% +$247K
XERS icon
2914
Xeris Biopharma Holdings
XERS
$1.45B
$685K ﹤0.01%
+444,924
New +$939K
ACNB icon
2915
ACNB Corp
ACNB
$655M
$682K ﹤0.01%
+22,977
New +$767K
BODI icon
2916
The Beachbody Company
BODI
$74.8M
$682K ﹤0.01%
11,370
+9,107
+402% +$738K
VRDN icon
2917
Viridian Therapeutics
VRDN
$2.67B
$681K ﹤0.01%
+58,915
New +$792K
VLGEA icon
2918
Village Super Market
VLGEA
$639M
$679K ﹤0.01%
29,782
-949
-3% -$22.4K
VWE
2919
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$679K ﹤0.01%
+86,392
New +$796K
FCUV icon
2920
Focus Universal
FCUV
$3.65M
$677K ﹤0.01%
+222
New +$758K
OUST icon
2921
Ouster
OUST
$2.92B
$674K ﹤0.01%
41,583
+10,332
+33% +$290K
SBDS
2922
DELISTED
Solo Brands Inc
SBDS
$674K ﹤0.01%
4,149
+3,705
+834% +$810K
CBAN icon
2923
Colony Bankcorp
CBAN
$467M
$673K ﹤0.01%
+44,555
New +$743K
NBN icon
2924
Northeast Bank
NBN
$1.14B
$670K ﹤0.01%
+18,337
New +$663K
HNST icon
2925
The Honest Company
HNST
$586M
$669K ﹤0.01%
229,332
-272,821
-54% -$985K

Similar funds

Nuveen's Q2 2022 Portfolio in Review

As of Q2 2022, Nuveen held 3,641 positions worth $259B, down 16% from $309B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2022 filing shows 264 new, 1,460 increased, 1,409 reduced and 415 closed positions. Its largest new stake was Coinbase: 292,590 shares worth $13.8M. The largest sale was Cisco, an estimated $321M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2022 buy was Coinbase: 292,590 shares worth $13.8M.
  • Nuveen added most to Linde in Q2 2022, an estimated $499M increase.
  • Nuveen's biggest Q2 2022 reduction was Cisco, cutting an estimated $321M.
  • Nuveen fully exited Cerner Corp in Q2 2022, selling an estimated $135M.
  • Nuveen's ten largest holdings make up 22% of its $259B portfolio in Q2 2022.
  • Nuveen opened 264 new positions and closed 415 in Q2 2022.
  • Nuveen's portfolio value fell 16% quarter-over-quarter to $259B.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.